HIGHLIGHTS
- who: Keita Nakamori from the Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan have published the research: Concurrent Palliative Radiation with Pembrolizumab for Platinum-Refractory Urothelial Carcinoma is Associated with Improved Overall Survival, in the Journal: (JOURNAL)
- what: The authors explored the possibility of survival benefits of palliative radiation treatment for platinum-refractory mUC patients treated with pembrolizumab.
- how: The authors conducted this study using a multi-institutional dataset from Osaka Medical and Pharmaceutical University (Osaka Japan) the Jikei University School of Medicine (Tokyo Japan) Tokyo Medical University (Tokyo Japan) and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.